TickerLeague

EPS (Diluted) for IQVIA (IQV)

According to IQVIA's latest reported financial statements, the company's current diluted EPS (TTM) is $7.86. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

TTM (last 4 quarters)

$7.86

YoY change

+4.7%

5Y CAGR

+40.5%

Peak year (2025)

$7.84

Latest annual

$7.84

EPS (Diluted) history chart for IQVIA (IQV) from 2010 to 2025

EPS (Diluted) history table for IQVIA (IQV) from 2010 to 2025

Fiscal yearPeriod endedReportedEPS (Diluted)YoY
2025$7.84+4.7%
2024$7.49+2.7%
2023$7.29+27.4%
2022$5.72+15.6%
2021$4.95+246.2%
2020$1.43+49.0%
2019$0.96-22.6%
2018$1.24-78.9%
2017$5.88+673.7%
2016$0.76-75.3%
2015$3.08+13.2%
2014$2.72+53.7%
2013$1.77+27.3%
2012$1.39-26.8%
2011$1.90+50.8%
2010$1.26

EPS (Diluted) values are taken from IQVIA's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

In 2025, IQVIA (IQV) diluted EPS totalled $7.84 – edged up 4.7% year-over-year.

Over 2020–2025 (5 years), IQVIA diluted EPS expanded at a +40.5% compound annual rate, sustaining 6 straight years of year-over-year growth.

The dataset's maximum diluted EPS sits at $7.84 (2025); the minimum reading of $0.76 dates to 2016.

Within Healthcare, IQVIA (IQV) ranks 7th among 8 peers we track. The peer median for diluted EPS is $13.16.

IQVIA EPS (Diluted) by Year

IQVIA EPS (Diluted) 2025: $7.84

IQVIA diluted EPS in 2025 was $7.84, edged up 4.7% from 2024. This figure represents the highest annual value in the available history.

IQVIA EPS (Diluted) 2024: $7.49

IQVIA diluted EPS in 2024 was $7.49, edged up 2.7% from 2023.

IQVIA EPS (Diluted) 2023: $7.29

IQVIA diluted EPS in 2023 was $7.29, grew 27.4% from 2022.

IQVIA EPS (Diluted) 2022: $5.72

IQVIA diluted EPS in 2022 was $5.72, grew 15.6% from 2021.

IQVIA EPS (Diluted) 2021: $4.95

IQVIA diluted EPS in 2021 was $4.95.

See more financial history for IQVIA (IQV).

Sector peers — EPS (Diluted)

Companies in the same sector as IQVIA, ranked by their latest diluted EPS.

CompanyEPS (Diluted)Sector
Novo Nordisk A/S (NVO)$23.03Healthcare
Eli Lilly and Company (LLY)$22.95Healthcare
Amgen Inc. (AMGN)$14.23Healthcare
UnitedHealth Group Incorporated (UNH)$13.23Healthcare
AstraZeneca PLC (AZN)$13.08Healthcare
Johnson & Johnson (JNJ)$11.03Healthcare
Merck & Co., Inc. (MRK)$7.28Healthcare
AbbVie Inc. (ABBV)$2.37Healthcare

Frequently asked questions

What is IQVIA's diluted EPS?

Latest reported diluted EPS for IQVIA (IQV) is $7.86 (period ending December 31, 2025).

How has IQVIA diluted EPS changed year-over-year?

IQVIA (IQV) diluted EPS changed +4.7% year-over-year on the latest annual filing.

What is the long-term growth rate of IQVIA diluted EPS?

IQVIA (IQV) diluted EPS compound annual growth rate is +40.5% over the most recent 5 years available.

When did IQVIA diluted EPS hit its highest annual value?

IQVIA diluted EPS reached its highest annual value of $7.84 in 2025.

What was IQVIA diluted EPS in 2024?

IQVIA (IQV) diluted EPS in 2024 was $7.49.

What was IQVIA diluted EPS in 2025?

IQVIA (IQV) diluted EPS in 2025 was $7.84.

Metrics overview

Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.